Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 24:13:814971.
doi: 10.3389/fphar.2022.814971. eCollection 2022.

Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer

Affiliations
Review

Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer

Xue Hu et al. Front Pharmacol. .

Abstract

Objective (s): In this mini-review, we aimed to discuss the Wnt/β-catenin signaling pathway modulation in triple-negative breast cancer, particularly the contribution of lncRNAs and miRNAs in its regulation and their possible entwining role in breast cancer pathogenesis, proliferation, migration, or malignancy. Background: Malignant tumor formation is very high for breast cancer in women and is a leading cause of death all over the globe. Among breast cancer subtypes, triple-negative breast cancer is rife in premenopausal women, most invasive, and prone to metastasis. Complex pathways are involved in this cancer's pathogenesis, advancement, and malignancy, including the Wnt/β-catenin signaling pathway. This pathway is conserved among vertebrates and is necessary for sustaining cell homeostasis. It is regulated by several elements such as transcription factors, enhancers, non-coding RNAs (lncRNAs and miRNAs), etc. Methods: We evaluated lncRNAs and miRNAs differentially expressed in triple-negative breast cancer (TNBC) from the cDNA microarray data set literature survey. Using in silico analyses combined with a review of the current literature, we anticipated identifying lncRNAs and miRNAs that might modulate the Wnt/β-catenin signaling pathway. Result: The miRNAs and lncRNAs specific to triple-negative breast cancer have been identified based on literature and database searches. Tumorigenesis, metastasis, and EMT were all given special attention. Apart from cross-talk being essential for TNBC tumorigenesis and treatment outcomes, our results indicated eight upregulated and seven downregulated miRNAs and 19 upregulated and three downregulated lncRNAs that can be used as predictive or diagnostic markers. This consolidated information could be useful in the clinic and provide a combined literature resource for TNBC researchers working on the Wnt/β-catenin miRNA/lncRNA axis. Conclusion: In conclusion, because the Wnt pathway and miRNAs/lncRNAs can modulate TNBC, their intertwinement results in a cascade of complex reactions that affect TNBC and related processes. Their function in TNBC pathogenesis has been highlighted in molecular processes underlying the disease progression.

Keywords: breast cancer; lncRNA; microRNA; pathogenesis; wnt/β-catenin.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Wnt/β-catenin pathway in TNBC instigation. Figure adapted from the KEGG pathway (https://www.genome.jp/pathway/map05224).
FIGURE 2
FIGURE 2
LncRNA–miRNA gene expression regulation in normal vs. cancer phenotype.

Similar articles

Cited by

References

    1. Agustsson A. S., Birgisson H., Agnarsson B. A., Jonsson T., Stefansdottir H., Wärnberg F., et al. (2020). In Situ breast Cancer Incidence Patterns in Iceland and Differences in Ductal Carcinoma In Situ Treatment Compared to Sweden. Sci. Rep. 10 (1), 17623. 10.1038/s41598-020-74134-5 - DOI - PMC - PubMed
    1. Ali Syeda Z., Langden S. S. S., Munkhzul C., Lee M., Song S. J. (2020). Regulatory Mechanism of MicroRNA Expression in Cancer. Int. J. Mol. Sci. 21 (5). 10.3390/ijms21051723 - DOI - PMC - PubMed
    1. Alraouji N. N., Al-Mohanna F. H., Ghebeh H., Arafah M., Almeer R., Al-Tweigeri T., et al. (2020). Tocilizumab Potentiates Cisplatin Cytotoxicity and Targets Cancer Stem Cells in Triple-Negative Breast Cancer. Mol. Carcinog. 59 (9), 1041–1051. 10.1002/mc.23234 - DOI - PubMed
    1. Arif K. M. T., Elliott E. K., Haupt L. M., Griffiths L. R. (2020). Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets. Cancers (Basel) 12 (10). 10.3390/cancers12102922 - DOI - PMC - PubMed
    1. Avery-Kiejda K. A., Braye S. G., Mathe A., Forbes J. F., Scott R. J. (2014). Decreased Expression of Key Tumour Suppressor microRNAs Is Associated with Lymph Node Metastases in Triple Negative Breast Cancer. BMC Cancer 14, 51. 10.1186/1471-2407-14-51 - DOI - PMC - PubMed

LinkOut - more resources